UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of April 2025
Commission File Number: 001-40614
PainReform LTD.
(Translation of registrant’s name into English)
65 Yigal Alon St., Tel Aviv 6744316
Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
On April 10, 2025, an Extraordinary General Meeting of Shareholders (the “Meeting”) of PainReform Ltd. (the
“Company”) approved each of the four proposals brought before the Company’s shareholders at the Meeting, in accordance with the majority required for each proposal. Each of those proposals was described in the Company’s Notice and Proxy Statement
with respect to the Meeting, dated February 27, 2025, attached as Exhibit 99.1 to the Company’s Form 6-K that was furnished to the U.S. Securities and Exchange Commission on February 27, 2025.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
PAINREFORM LTD.
|
|
|
|
|
Date: April 10, 2025
|
/s/ Ehud Geller
|
|
|
Ehud Geller
Interim Chief Executive Officer
|